Nautilus Biotechnology, Inc.NAUTNASDAQ
LOADING
|||
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 9.50% |
| Q2 2025 | 9.27% |
| Q1 2025 | 5.69% |
| Q4 2024 | -4.61% |
| Q3 2024 | 8.12% |
| Q2 2024 | 3.79% |
| Q1 2024 | -8.03% |
| Q4 2023 | -4.85% |
| Q3 2023 | -0.31% |
| Q2 2023 | -5.29% |
| Q1 2023 | -10.77% |
| Q4 2022 | -3.06% |
| Q3 2022 | -2.25% |
| Q2 2022 | 3.43% |
| Q1 2022 | 4.72% |
| Q4 2021 | -15.43% |
| Q3 2021 | -36.19% |
| Q2 2021 | -500.96% |
| Q1 2021 | 66.54% |
| Q4 2020 | -32.11% |
| Q3 2020 | -18.44% |
| Q2 2020 | -13.45% |
| Q1 2020 | -744.23% |
| Q4 2019 | -99.44% |
| Q3 2019 | -101.80% |
| Q2 2019 | 42.72% |
| Q1 2019 | 99.86% |
| Q4 2018 | 0.00% |